Category Archives: Businessman

Fortress Investment Group bolstering Times Square

Fortress Investment Group is bolstering its presence on Times Square in New York City.

According to a Sept. 11 article published in Livenewspaper, FIG purchased the historic Palace Theater with several partners back in February. Located just across the street from the currently under-construction Marriott Edition, the hotel that houses the Palace was sold before those renovations began.

Fortress Investment Group teamed up with Maefield Development to purchase 20 Times Square, buying out their partners including New Valley, Ian Schrager, Steve Witkoff and Winthrop Realty Trust for $1.53 billion, according to the article. The deal gave FIG full ownership of the property.

FIG is an investment management firm that oversees alternative assets in private equity, liquid hedge funds and credit funds. Highly diversified, it acts on behalf of more than 1,500 institutional and private clients.

The building was originally purchased by investors for $430 million in 2012. Following the purchase, it was announced that a luxury hotel would be immediately built, but construction did not begin until 2015 due to a number of problems that slowed the effort.

The Edition itself is 39 stories tall and has 450 rooms, plus additional retail space. Maefield was seeking additional capital for construction when the most recent deal closed.

The partners are planning to seek $1.3 billion to cover construction costs on their numerous Times Square holdings. They hope to rehabilitate the Palace Theater, expand the hotel and build a massive outdoor sign screen.

Fortress Investment Group was purchased by Japan’s SoftBank Group in 2017 for $3.3 billion and remains headquartered in New York City. Founded in 1997, FIG is the first publicly traded private equity frim in the United States.

Fortress Investment Group currently manages more than $70 billion in assets. and was named the 2014 Hedge Fund Manager of the Year, in addition to receiving several other awards.

Vijay Eswaran Shares A Philosophy Which Helps People To Prosper

Many people never fulfill their potential because they do not know how to tap into the power they have within themselves. For more than two decades, QI Group co-founder, chairman and CEO Vijay Eswaran has been helping people draw on their inner strength and creative power to improve their lives. Eswaran teaches people a step-by-step method for using creative visualization, faith, proper planning and consistent effort to make their dreams a reality. That method is outlined in his books ‘As I See It’, ‘In The Thinking Zone’, ‘On The Wings of Thought’, ’18 Stepping Stones’ and ‘In the Sphere of Silence’.

Vijay Eswaran also understands that fear often creates a barrier than prevents people for attaining their goals. In his articles 5 Cs of Servant Leadership, Two Minutes From The Abyss, 3 Ways Fear Drives Success and The Stages of Change, he explains how people can use fear to their advantage and enjoy great achievement. Eswaran has also delivered powerful motivational speeches at sales conventions, on college campuses and at economic forums that have transformed the way people approach life and led to great success. Those results have made him a legendary figure in Asia and elsewhere.

When Vijay Eswaran began building the QI Group in 1998, many people looked at the dire economic conditions in Asia and predicted the company would fail. Instead, Eswaran taught his staff to focus on their goals, envision people buying their products and becoming prosperous. As a result, the independent marketing representatives of the QI Group were confident their business efforts would succeed. That strong belief that they would attain their goals put them in a positive frame of mind and their results matched their expectations. That’s the basic premise of Vijay Eswaran’s philosophy.

Great opportunities are available to people in all walks of life all over the world. Once people are convinced of and confident in their inner power, they can take advantage of those opportunities. Vijay Eswaran has been able to help people draw on their capacity for greatness and make them and the people around them happier, healthier and more prosperous.

[Top]

Sahm Adrangi and Kerrisdale Capital on the Proteostasis Therapeutics’ drug

Sahm Adrangi and Kerrisdale Capital on the Proteostasis Therapeutics’ drug

Be introduced to 33-year-old Sahm Adrangi, the founder, and CIO of Kerrisdale Capital Management LLC which is a New York-based company. Kerrisdale Capital is an investment manager that is committed to long-term investments and shares its investment views with the more extensive investment community. He is a generalist who’s investments are value driven. Also, he has worked for Longacre Fund Management LLC, Chain Capital Partners, and Deutsche Bank’s leveraged finance investment banking. He attended the Yale University and received a bachelor of arts in economics.

Sahm Adrangi’s company, Kerrisdale Capital, issued a negative report on Proteostasis Therapeutics and announced a conference-call. Proteostasis Therapeutics is a clinical biopharmaceutical firm and their top drug, PTI-428, focuses on curing the genetic disorder cystic fibrosis. The firm claimed that the drug in some way increased the levels of the messenger RNA and protein consistent with the CFTR gene which malfunctions in people suffering from the disease thus resulting in fatal symptoms. Clinical data show that this drug is ineffectual.

The supposed success of the drug in its proof-of-concept trials emanates from the peculiar underperformance of the 4-person placebo group. Also, people taking the medication hardly improved. Sahm Adrangi and his company believe that the deception of the drug’s performance will fade away. Also, the drug wasn’t able to deliver convincing effectiveness results in a previous trial. Proteostasis had also planned to study on many matters, for example, the patient-reported health satisfaction, it is a mystery how the studies have never been discussed.

Sahm Adrangi’s company believes that Proteostasis has a tendency of doing away with disagreeable and unclear findings. A semi-independent team of researchers carried out an in vitro study on PTI-428, a study which produced alarmingly weak results. Proteostasis did not acknowledge this results. The drug does not work as projected and does to a limited degree anything of value in the world.

http://nymag.com/news/business/boom-brands/sam-adrangi-kerrisdale-capital-2013-10/

, , , , , , , ,
[Top]

Eric Lefkofsky: Building an Impressive Technology

Eric Lefkofsky is one of the founders of Tempus, and he is currently serving as the company’s chief executive officer. He has invested in a lot of companies before, but he has focused most of his career in the development of Tempus. He developed the company because he wanted to find the best solution on how to address the growing problem with cancer. Through his knowledge about the disease, he is trying to figure out how technology can assist the scientists around the world and create a method on how to treat the patients diagnosed with the disease. After continuous research and exploration, Eric Lefkofsky managed to develop a system that would collect the medical data of patients who are diagnosed with the disease. His primary objective is to help these people who are experiencing hardships battling the disease, and he wishes that his creation would help them shortly.

Scientists working at Tempus are trying to redefine the genomic data of a patient who are diagnosed with the disease. They would study it thoroughly until they manage to create a system of treatment that can be applied to other patients. Tempus is using an advanced algorithm that would combine all treatment methods applied by different doctors around the world. By collecting a huge amount of data from the patients, the system can create new information about how these symptoms react with each other and what things can be used to stop them. Doctors around the world have been praising the system because of the accurate information that it provides, and at the same time, it makes their work easier and more manageable.

Through the years of operation, Tempus managed to create a gigantic system that would be able to collect, analyze, and sample data to help in the advancement of global healthcare. Eric Lefkofsky wanted to thank the people who have helped him develop the system, and he assured the public that there would be more updates to the technology that he developed. So far, Tempus is offering a wide range of products and services to their clients, and it is used by a lot of doctors around the world to help them with their jobs.

[Top]